Myeloid derived suppressor cells in physiological and pathological conditions: The good, the bad, and the ugly

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Myeloid derived suppressor cells (MDSCs), a heterogeneous population of myeloid progenitors, are recognized as a key element in tumor escape and progression the importance of MDSCs in human malignancies has been demonstrated in recent years, and new approaches targeting their suppressive/tolerogenic action are currently being tested in both preclinical model and clinical trials. However, emerging evidence suggests that MDSCs may play a prominent role as regulator of the physiologic, the chronic, and the pathologic immune responses. This review will focus on the biology of MDSC in light of these new findings and the possible role of this myeloid population not only in the progression of the tumor but also in its initiation.

Original languageEnglish
Pages (from-to)172-184
Number of pages13
JournalImmunologic Research
Volume57
Issue number1-3
DOIs
StatePublished - Dec 1 2013

Fingerprint

Tumor Escape
Population
Neoplasms
Clinical Trials
Myeloid-Derived Suppressor Cells

Keywords

  • Carcinogenesis
  • Chronic inflammation
  • MDSCs subsets
  • Myeloid derived suppressor cells
  • Physiological immune response
  • Tumor progression

ASJC Scopus subject areas

  • Immunology

Cite this

Myeloid derived suppressor cells in physiological and pathological conditions : The good, the bad, and the ugly. / Serafini, Paolo.

In: Immunologic Research, Vol. 57, No. 1-3, 01.12.2013, p. 172-184.

Research output: Contribution to journalArticle

@article{0e834cd52ea04995b8a04e2c235ce1f4,
title = "Myeloid derived suppressor cells in physiological and pathological conditions: The good, the bad, and the ugly",
abstract = "Myeloid derived suppressor cells (MDSCs), a heterogeneous population of myeloid progenitors, are recognized as a key element in tumor escape and progression the importance of MDSCs in human malignancies has been demonstrated in recent years, and new approaches targeting their suppressive/tolerogenic action are currently being tested in both preclinical model and clinical trials. However, emerging evidence suggests that MDSCs may play a prominent role as regulator of the physiologic, the chronic, and the pathologic immune responses. This review will focus on the biology of MDSC in light of these new findings and the possible role of this myeloid population not only in the progression of the tumor but also in its initiation.",
keywords = "Carcinogenesis, Chronic inflammation, MDSCs subsets, Myeloid derived suppressor cells, Physiological immune response, Tumor progression",
author = "Paolo Serafini",
year = "2013",
month = "12",
day = "1",
doi = "10.1007/s12026-013-8455-2",
language = "English",
volume = "57",
pages = "172--184",
journal = "Immunologic Research",
issn = "0257-277X",
publisher = "Humana Press",
number = "1-3",

}

TY - JOUR

T1 - Myeloid derived suppressor cells in physiological and pathological conditions

T2 - The good, the bad, and the ugly

AU - Serafini, Paolo

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Myeloid derived suppressor cells (MDSCs), a heterogeneous population of myeloid progenitors, are recognized as a key element in tumor escape and progression the importance of MDSCs in human malignancies has been demonstrated in recent years, and new approaches targeting their suppressive/tolerogenic action are currently being tested in both preclinical model and clinical trials. However, emerging evidence suggests that MDSCs may play a prominent role as regulator of the physiologic, the chronic, and the pathologic immune responses. This review will focus on the biology of MDSC in light of these new findings and the possible role of this myeloid population not only in the progression of the tumor but also in its initiation.

AB - Myeloid derived suppressor cells (MDSCs), a heterogeneous population of myeloid progenitors, are recognized as a key element in tumor escape and progression the importance of MDSCs in human malignancies has been demonstrated in recent years, and new approaches targeting their suppressive/tolerogenic action are currently being tested in both preclinical model and clinical trials. However, emerging evidence suggests that MDSCs may play a prominent role as regulator of the physiologic, the chronic, and the pathologic immune responses. This review will focus on the biology of MDSC in light of these new findings and the possible role of this myeloid population not only in the progression of the tumor but also in its initiation.

KW - Carcinogenesis

KW - Chronic inflammation

KW - MDSCs subsets

KW - Myeloid derived suppressor cells

KW - Physiological immune response

KW - Tumor progression

UR - http://www.scopus.com/inward/record.url?scp=84891486024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891486024&partnerID=8YFLogxK

U2 - 10.1007/s12026-013-8455-2

DO - 10.1007/s12026-013-8455-2

M3 - Article

C2 - 24203443

AN - SCOPUS:84891486024

VL - 57

SP - 172

EP - 184

JO - Immunologic Research

JF - Immunologic Research

SN - 0257-277X

IS - 1-3

ER -